Semaglutide, tirzepatide, and retatrutide can all support healthier habits by helping patients manage appetite, cravings, and blood sugar
With the US GLP-1 market valued at $49.3bn in 2024, and growing at a CAGR of 11%1, there is tremendous demand as these therapies become the go-to options for weight loss
A nutritional supplement is no substitute for a varied diet
Cardio Diabetic : Our cardiovascular medications are formulated to address various aspects of heart health, supporting individuals in managing conditions such as hypertension and other cardiovascular disorders Products includes Tablets and Capsules
Without sufficient glutathione, cellular detoxification capacities are severely compromised (Ballatori et al., Free Radic Biol Med 2009)
(Article in Japanese) Kanda H, Yamawaki K